• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急诊中心成年镰状细胞病患者急性疼痛管理的循证实践标准护理

Evidence-Based Practice Standard Care for Acute Pain Management in Adults With Sickle Cell Disease in an Urgent Care Center.

作者信息

Kim Sunghee, Brathwaite Ron, Kim Ook

机构信息

Department of Family Medicine, Loma Linda University Medical East Campus Hospital Urgent Care, Loma Linda, California (Drs S. Kim and Brathwaite); and Department of Internal Medicine, Loma Linda University Medical Center, Loma Linda, California (Dr O. Kim).

出版信息

Qual Manag Health Care. 2017 Apr/Jun;26(2):108-115. doi: 10.1097/QMH.0000000000000135.

DOI:10.1097/QMH.0000000000000135
PMID:28375958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5381468/
Abstract

BACKGROUND

Vaso-occlusive episodes (VOEs) with sickle cell disease (SCD) require opioid treatment. Despite evidence to support rapid pain management within 30 minutes, care for these patients does not consistently meet this benchmark. This quality improvement study sought to decrease the first analgesic administration time, increase patient satisfaction, and expedite patient flow.

METHODS

A prospective pre-/postevaluation design was used to evaluate outcomes with patients 18 years or older with VOEs in an urgent care (UC) center after implementation of evidence-based practice standard care (EBPSC). A pre- and postevaluation survey of SCD patients' satisfaction with care and analogous surveys of the UC team to assess awareness of EBPSC were used. A retrospective review of the electronic medical records of patients with VOEs compared mean waiting time from triage to the first analgesic administration and the mean length of stay (LOS) over 6 months.

RESULTS

Implementing EBPSC decreased the mean time of the first analgesic administration (P = .001), significantly increased patient satisfaction (P = .002), and decreased the mean LOS (P = .010).

CONCLUSION

Implementing EBPSC is a crucial step for improving the management of VOEs and creating a positive patient experience. The intervention enhances the quality of care for the SCD population in a UC center.

摘要

背景

镰状细胞病(SCD)的血管闭塞性发作(VOE)需要使用阿片类药物治疗。尽管有证据支持在30分钟内进行快速疼痛管理,但对这些患者的护理并未始终达到这一标准。这项质量改进研究旨在缩短首次镇痛给药时间,提高患者满意度,并加快患者流程。

方法

采用前瞻性前后评估设计,对一家紧急护理(UC)中心实施循证实践标准护理(EBPSC)后18岁及以上VOE患者的结局进行评估。使用了对SCD患者护理满意度的前后评估调查以及对UC团队进行的类似调查,以评估对EBPSC的知晓情况。对VOE患者的电子病历进行回顾性审查,比较从分诊到首次镇痛给药的平均等待时间以及6个月内的平均住院时间(LOS)。

结果

实施EBPSC缩短了首次镇痛给药的平均时间(P = .001),显著提高了患者满意度(P = .002),并缩短了平均住院时间(P = .010)。

结论

实施EBPSC是改善VOE管理并创造积极患者体验的关键步骤。该干预措施提高了UC中心对SCD患者群体的护理质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a467/5381468/b2150539c8b5/qualm-26-108-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a467/5381468/122d532a03c3/qualm-26-108-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a467/5381468/b2150539c8b5/qualm-26-108-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a467/5381468/122d532a03c3/qualm-26-108-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a467/5381468/b2150539c8b5/qualm-26-108-g002.jpg

相似文献

1
Evidence-Based Practice Standard Care for Acute Pain Management in Adults With Sickle Cell Disease in an Urgent Care Center.急诊中心成年镰状细胞病患者急性疼痛管理的循证实践标准护理
Qual Manag Health Care. 2017 Apr/Jun;26(2):108-115. doi: 10.1097/QMH.0000000000000135.
2
Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department.改善儿科急诊部血管阻塞性发作的管理。
Pediatrics. 2015 Oct;136(4):e1016-25. doi: 10.1542/peds.2014-3470. Epub 2015 Sep 21.
3
Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.低剂量氯胺酮输注用于镰状细胞病成人血管闭塞发作期间的辅助治疗:病例系列
J Pain Palliat Care Pharmacother. 2018 Mar;32(1):20-26. doi: 10.1080/15360288.2018.1468383. Epub 2018 May 23.
4
An innovative intervention for the prevention of vaso-occlusive episodes in sickle cell disease.一种用于预防镰状细胞病血管阻塞发作的创新干预措施。
Hematology. 2023 Dec;28(1):2215575. doi: 10.1080/16078454.2023.2215575.
5
Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care.采用护理路径对镰状细胞病患者的血管闭塞性疼痛危象进行住院医师管理。
Hosp Pract (1995). 2014 Apr;42(2):70-6. doi: 10.3810/hp.2014.04.1105.
6
Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management.成人急诊科镰状细胞疼痛危象患者:一项质量改进学习合作模式的结果,旨在改善镇痛管理。
Acad Emerg Med. 2012 Apr;19(4):430-8. doi: 10.1111/j.1553-2712.2012.01330.x.
7
An innovative short-stay health care model for treatment of uncomplicated vaso-occlusive crisis in adult sickle cell disease patients in Canada to reduce emergency department utilization.一种创新的短期住院医疗模式,用于治疗加拿大成人镰状细胞病患者的单纯血管阻塞性危象,以减少急诊科的使用。
CJEM. 2019 Jan;21(1):55-62. doi: 10.1017/cem.2017.413. Epub 2017 Oct 17.
8
Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.使用临床路径改善小儿镰状细胞病血管阻塞性危象疼痛的急性管理。
Pediatr Blood Cancer. 2014 Apr;61(4):693-6. doi: 10.1002/pbc.24864. Epub 2013 Nov 19.
9
Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.成人镰状细胞病血管闭塞性危象患者肠外阿片类药物剂量的比较
J Pain Palliat Care Pharmacother. 2018 Dec;32(4):201-207. doi: 10.1080/15360288.2019.1577938. Epub 2019 Mar 21.
10
Do children with sickle cell disease receive disparate care for pain in the emergency department?患有镰状细胞病的儿童在急诊科接受的疼痛治疗是否存在差异?
J Emerg Med. 2010 Nov;39(5):691-5. doi: 10.1016/j.jemermed.2009.06.003. Epub 2009 Aug 22.

引用本文的文献

1
Sickle cell disease: understanding pathophysiology, clinical features and advances in gene therapy approaches.镰状细胞病:了解病理生理学、临床特征及基因治疗方法的进展
Front Pharmacol. 2025 Aug 22;16:1630994. doi: 10.3389/fphar.2025.1630994. eCollection 2025.
2
"The project did not come to us with a solution": Perspectives of research teams on implementing a study about electronic health record-embedded individualized pain plans for emergency department treatment of vaso-occlusive episodes in adults with sickle cell disease.“项目没有为我们提供解决方案”:研究团队对实施一项关于电子健康记录嵌入式个体化疼痛计划的看法,该计划用于治疗镰状细胞病成人急诊科血管阻塞性发作。
BMC Health Serv Res. 2023 Nov 13;23(1):1245. doi: 10.1186/s12913-023-10255-7.
3

本文引用的文献

1
Management of Sickle Cell Disease: Recommendations from the 2014 Expert Panel Report.镰状细胞病的管理:2014年专家小组报告的建议
Am Fam Physician. 2015 Dec 15;92(12):1069-76.
2
Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department.改善儿科急诊部血管阻塞性发作的管理。
Pediatrics. 2015 Oct;136(4):e1016-25. doi: 10.1542/peds.2014-3470. Epub 2015 Sep 21.
3
Age-Related Emergency Department Reliance in Patients with Sickle Cell Disease.镰状细胞病患者与年龄相关的急诊科就诊依赖情况
A rapid evidence assessment of sickle cell disease educational interventions.镰状细胞病教育干预措施的快速证据评估。
J Clin Nurs. 2023 Mar;32(5-6):812-824. doi: 10.1111/jocn.16370. Epub 2022 May 19.
4
Opioid Use in Patients With Sickle Cell Disease During a Vaso-Occlusive Crisis: A Systematic Review.镰状细胞病患者血管闭塞性危象期间阿片类药物的使用:一项系统评价
Cureus. 2022 Jan 21;14(1):e21473. doi: 10.7759/cureus.21473. eCollection 2022 Jan.
5
Specifying sickle cell disease interventions: a study protocol of the Sickle Cell Disease Implementation Consortium (SCDIC).明确镰状细胞病干预措施:镰状细胞病实施联盟(SCDIC)的一项研究方案
BMC Health Serv Res. 2018 Jun 27;18(1):500. doi: 10.1186/s12913-018-3297-1.
J Emerg Med. 2015 Oct;49(4):513-522.e1. doi: 10.1016/j.jemermed.2014.12.080. Epub 2015 Apr 21.
4
Timing of opioid administration as a quality indicator for pain crises in sickle cell disease.阿片类药物给药时机作为镰状细胞病疼痛危象的质量指标。
Pediatrics. 2015 Mar;135(3):475-82. doi: 10.1542/peds.2014-2874. Epub 2015 Feb 9.
5
Quality improvement process in a sickle cell infusion center.镰状细胞输注中心的质量改进流程。
Am J Med. 2015 May;128(5):541-4. doi: 10.1016/j.amjmed.2014.11.020. Epub 2014 Dec 9.
6
Timely pain management in the emergency department.急诊科的及时疼痛管理。
J Emerg Med. 2015 Mar;48(3):267-73. doi: 10.1016/j.jemermed.2014.09.009. Epub 2014 Nov 7.
7
Safety of an ED High-Dose Opioid Protocol for Sickle Cell Disease Pain.用于镰状细胞病疼痛的急诊科高剂量阿片类药物方案的安全性
J Emerg Nurs. 2015 May;41(3):227-35. doi: 10.1016/j.jen.2014.07.014. Epub 2014 Sep 18.
8
Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.镰状细胞病的管理:专家小组成员 2014 年循证报告的总结。
JAMA. 2014 Sep 10;312(10):1033-48. doi: 10.1001/jama.2014.10517.
9
Sickle cell disease in the emergency department.急诊科中的镰状细胞病
Emerg Med Clin North Am. 2014 Aug;32(3):629-47. doi: 10.1016/j.emc.2014.04.011. Epub 2014 Jun 7.
10
Sickle cell disease patients with and without extremely high hospital use: pain, opioids, and coping.有和没有极高住院使用率的镰状细胞病患者:疼痛、阿片类药物及应对方式。
J Pain Symptom Manage. 2015 Mar;49(3):539-47. doi: 10.1016/j.jpainsymman.2014.06.007. Epub 2014 Jul 22.